NPS PHARMACEUTICALS, INC.

Inactive Instrument

NPS Pharmaceuticals, Inc. Stock

Stocks

US62936P1030

Biotechnology & Medical Research

End-of-day quote Nasdaq
- ^USD	-

12/02/15	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
26/01/15	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE

Latest news: NPS Pharmaceuticals, Inc.

12/02/15	NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval	RE
26/01/15	NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase	RE
14/01/15	Aegerion Pharmaceuticals : Exclusive: Top investors push Aegerion to oust CEO, consider sale - sources	RE
13/01/15	Alcoa : Wall St. falls; energy shares dragged down further by oil	RE
17/12/14	AbbVie : Shire considering bid for NPS Pharmaceuticals - Bloomberg	RE
02/06/14	NPS Pharmaceuticals : Shire secures $5 billion funding for NPS Pharma bid - The Times	RE

Press Releases: NPS Pharmaceuticals, Inc.

21/02/15	NPS Pharmaceuticals : Shire Completes Acquisition of NPS Pharma	PR
06/02/15	NPS Pharmaceuticals : Biotech Stocks Review - Arena Pharma, Amgen, NPS Pharma, ZIOPHARM Oncology, and Advaxis	PR
24/01/15	NPS Pharmaceuticals : FDA Approves Natpara® (parathyroid hormone) for Injection as an Adjunct to Calcium and Vitamin D to Control Hypocalcemia in Patients with Hypoparathyroidism	BU
16/01/15	NPS Pharmaceuticals : NPSP INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. in Connection with the Fairness of the Sale of the Company to Shire plc	BU
14/01/15	NPS Pharmaceuticals : NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. Concerning the Fairness of the Sale of the Company to Shire plc	BU

More press releases

News in other languages: NPS Pharmaceuticals, Inc.

12/02/15	Shire : Hausse du résultat du T4, le titre monte
26/01/15	American Airlines : Les valeurs à suivre sur les marchés américains
26/01/15	USA-Les valeurs à suivre à Wall Street
13/01/15	Foundation Medicine : Wall Street clôture en baisse avec le pétrole
13/01/15	Wall Street finit en baisse avec le pétrole

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	WUXI APPTEC CO., LTD.	+1.76%	+3.62%	+49.92%	+101.12%	69.69B
	ARGENX SE	+2.29%	+1.43%	+38.39%	+77.03%	61.24B
	INSMED INCORPORATED	+1.14%	-2.59%	-14.37%	+365.92%	26.77B
	WUXI BIOLOGICS (CAYMAN) INC.	+0.32%	+5.47%	+27.74%	+14.12%	26.12B
	BIONTECH SE	+2.95%	+2.34%	+0.52%	-12.74%	24.07B
	GENMAB A/S	+1.49%	+7.73%	+26.85%	-15.89%	20.39B
	PHARMAESSENTIA CORPORATION	-0.83%	-11.15%	+169.70%	+295.44%	15.72B
	EXELIXIS, INC.	+3.01%	+1.85%	+44.63%	+168.18%	14.07B
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.17%	-2.74%	-9.79%	+484.05%	14.03B
	Average	+1.37%	-1.18%	+37.07%	+164.14%	30.23B
	Weighted average by Cap.	+1.60%	+0.20%	+36.34%	+129.00%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!